Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS)
CNY 8.44
(0.12%)
CNY 8.44
(0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.5 Billion | 2.06 Billion | 1.73 Billion | 1.58 Billion | 698.38 Million | 1.44 Billion |
| Net Income | -97.01 Million | 491.41 Million | 510.63 Million | 723.16 Million | 323.26 Million | -236.97 Million |
| Depreciation & Amortization | 1.04 Billion | 1.03 Billion | 951.73 Million | 874.33 Million | 885.31 Million | 745.02 Million |
| Deferred income taxes | -78.78 Million | 20.55 Million | 33.33 Million | -7.41 Million | -36.23 Million | -20.88 Million |
| Stock-based compensation | 9.15 Million | 46.69 Million | 20.26 Million | - | - | - |
| Change in working capital | 36.13 Million | 2.83 Million | -184.99 Million | -457.04 Million | -530.39 Million | 260.74 Million |
| Other non-cash items | 214.51 Million | 464.29 Million | 405.54 Million | 449.15 Million | 20.2 Million | 677.5 Million |
| Investing Cash Flow | -338.7 Million | -578.78 Million | -493.28 Million | 1 Billion | 216.1 Million | -1.38 Billion |
| Investments in PPE | -240.03 Million | -530.61 Million | -622.37 Million | -692.04 Million | -1.07 Billion | -1.6 Billion |
| Acquisitions | 23.09 Million | 43.45 Million | 203.67 Million | 422.14 Million | 874.28 Million | - |
| Investment purchases | -1.5 Million | -118.72 Million | -1.74 Billion | -2.68 Billion | -2.33 Billion | -1.16 Billion |
| Sales/Maturities of investments | 15.73 Million | 90.48 Million | 1.66 Billion | 3.9 Billion | 2.34 Billion | 1.46 Billion |
| Other Investing Activities | -162.45 Million | -63.38 Million | 2.45 Million | 57.96 Million | 408.28 Million | -80.37 Million |
| Financing Cash Flow | -1 Billion | -1.5 Billion | -2.07 Billion | -2.22 Billion | -866.88 Million | -720.59 Million |
| Debt repayment | -57.6 Million | -6.2 Billion | -8.88 Billion | -7.18 Billion | -8.77 Billion | -7.68 Billion |
| Dividends payments | -199.18 Million | -166.25 Million | -57.97 Million | -48.21 Million | -499.34 Million | -538.49 Million |
| Common Stock Repurchased | -109.23 Million | -211.66 Million | -101.62 Million | - | - | - |
| Common Stock Issuance | - | 211.66 Million | 101.62 Million | - | - | - |
| Other Financing Activities | -705.51 Million | 5.07 Billion | 7.23 Billion | 5.41 Billion | 8.4 Billion | 7.5 Billion |
| Accounts receivables | 118.03 Million | -398.92 Million | -31.43 Million | -71.73 Million | -165.77 Million | 276.76 Million |
| Accounts payables | 167.6 Million | 362.17 Million | -585.72 Million | 300.38 Million | 21.69 Million | 105.7 Million |
| Inventory | -170.72 Million | 19.03 Million | 398.82 Million | -678.28 Million | -350.08 Million | -100.83 Million |
| Other working capital | 9.15 Million | 20.55 Million | 33.33 Million | -7.41 Million | -36.23 Million | 361.58 Million |
| Cash at beginning of period | 1.16 Billion | 1.17 Billion | 2 Billion | 1.66 Billion | 1.62 Billion | 2.27 Billion |
| Cash at end of period | 1.32 Billion | 1.16 Billion | 1.17 Billion | 2 Billion | 1.66 Billion | 1.62 Billion |
| Capital Expenditure | -240.03 Million | -530.61 Million | -622.37 Million | -692.04 Million | -1.07 Billion | -1.6 Billion |
| Effect of forex changes on cash | 4.71 Million | 6.52 Million | -600.22 Thousand | -20.26 Million | -7.58 Million | -2.97 Million |
| Net cash flow / Change in cash | 164.47 Million | -11.92 Million | -831.37 Million | 347.88 Million | 40.02 Million | -659.24 Million |
| Free Cash Flow | 1.26 Billion | 1.53 Billion | 1.11 Billion | 897.56 Million | -378.19 Million | -154.72 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 80.07 Million | 186.71 Million | 248.53 Million | -97.01 Million | -550.26 Million | 37.68 Million |
| Depreciation & Amortization | - | 272.93 Million | 272.93 Million | 1.04 Billion | 259.14 Million | -523.83 Million |
| Deferred income taxes | - | - | - | -78.78 Million | - | 408.85 Million |
| Stock-based compensation | - | 4.92 Million | - | 9.15 Million | 9.15 Million | -19.82 Million |
| Change in working capital | - | -20.07 Million | - | 36.13 Million | -43.53 Million | 134.8 Million |
| Other non-cash items | 594.07 Million | 568.48 Million | 66.55 Million | 214.51 Million | 989.55 Million | 541.63 Million |
| Investing Cash Flow | -59.88 Million | -31.39 Million | -44.93 Million | -338.7 Million | 1.7 Million | -16.62 Million |
| Investments in PPE | -50.01 Million | -31.95 Million | -34.4 Million | -240.03 Million | 8.8 Million | -52.68 Million |
| Acquisitions | 124.78 Thousand | 605.54 Thousand | 278.31 Thousand | 23.09 Million | 124.59 Thousand | 18.8 Million |
| Investment purchases | -9.23 Million | - | -30 Million | -1.5 Million | -1.3 Million | 16.24 Million |
| Sales/Maturities of investments | - | - | - | 15.73 Million | -25.47 Million | 941.77 Thousand |
| Other Investing Activities | -633.07 Thousand | -45.56 Thousand | 19.18 Million | -162.45 Million | 10.36 Million | 67.06 Thousand |
| Financing Cash Flow | -550.62 Million | -651.8 Million | -271.79 Million | -1 Billion | -239.57 Million | -340.68 Million |
| Debt repayment | -203.97 Million | -192.35 Million | -601.29 Million | -57.6 Million | -225.15 Million | -809.8 Million |
| Dividends payments | -35.38 Million | -38.81 Million | -38.02 Million | -199.18 Million | -199.18 Million | -37.89 Million |
| Common Stock Repurchased | 1.54 Billion | -1.54 Billion | - | -109.23 Million | -109.23 Million | 25.66 Million |
| Common Stock Issuance | - | - | - | - | - | -25.66 Million |
| Other Financing Activities | -311.27 Million | 1.09 Billion | -835.07 Million | -705.51 Million | 21.97 Million | 507.01 Million |
| Accounts receivables | - | -225.64 Million | - | 118.03 Million | 118.03 Million | 205.59 Million |
| Accounts payables | - | - | - | 167.6 Million | - | 19.82 Million |
| Inventory | - | 200.63 Million | - | -170.72 Million | -170.72 Million | -70.79 Million |
| Other working capital | - | 4.92 Million | - | 9.15 Million | 9.15 Million | -19.82 Million |
| Cash at beginning of period | 1.12 Billion | 1.56 Billion | 1.32 Billion | 1.16 Billion | 1.38 Billion | 1.16 Billion |
| Cash at end of period | 1.19 Billion | 1.44 Billion | 1.32 Billion | 1.32 Billion | 1.32 Billion | 1.38 Billion |
| Capital Expenditure | -50.01 Million | -31.95 Million | -34.4 Million | -240.03 Million | 8.8 Million | -52.68 Million |
| Effect of forex changes on cash | 1.07 Million | 626.92 Thousand | 892.11 Thousand | 4.71 Million | 1.29 Million | -1.42 Million |
| Net cash flow / Change in cash | 64.71 Million | -126.53 Million | -755.36 Thousand | 164.47 Million | -54.94 Million | 220.59 Million |
| Free Cash Flow | 624.13 Million | 450.3 Million | 280.68 Million | 1.26 Billion | 188.95 Million | 526.64 Million |
0292
4DS
601328
KFR
FMBL
AZO